CAS 942206-85-1
:Gsk 10116790A
Description:
GSK 10116790A, with the CAS number 942206-85-1, is a chemical compound that has been investigated primarily for its potential therapeutic applications, particularly in the field of neuroscience. It is classified as a small molecule and is known to act as a selective modulator of certain receptors in the central nervous system. The compound exhibits properties that may influence neurotransmitter systems, making it a candidate for research into treatments for various neurological disorders. Its molecular structure includes specific functional groups that contribute to its biological activity and pharmacokinetic profile. While detailed information on its solubility, stability, and specific interactions may vary, ongoing studies aim to elucidate its mechanism of action and therapeutic potential. As with many investigational compounds, safety and efficacy assessments are critical components of its development process. Overall, GSK 10116790A represents a promising area of research within medicinal chemistry and pharmacology.
Formula:C28H32Cl2N4O6S2
InChI:InChI=1S/C28H32Cl2N4O6S2/c1-17(2)13-21(31-26(36)24-14-18-5-3-4-6-23(18)41-24)27(37)33-9-11-34(12-10-33)28(38)22(16-35)32-42(39,40)25-8-7-19(29)15-20(25)30/h3-8,14-15,17,21-22,32,35H,9-13,16H2,1-2H3,(H,31,36)/t21-,22-/m0/s1
InChI key:InChIKey=IVYQPSHHYIAUFO-VXKWHMMOSA-N
SMILES:C(N[C@H](C(=O)N1CCN(C([C@@H](NS(=O)(=O)C2=C(Cl)C=C(Cl)C=C2)CO)=O)CC1)CC(C)C)(=O)C3=CC=4C(S3)=CC=CC4
Synonyms:- GSK1016790A
- GSK1016790A;GSK-1016790A;GSK 1016790A
- CS-2774
- (N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide
- GSK-1016790A;GSK 1016790A
- N-((S)-1-(4-(((2,4-dichlorophenyl)sulfonyl)-L-seryl)piperazin-1-yl)-4-methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxamide
- GSK101
- N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide
- Benzo[b]thiophene-2-carboxamide, N-[(1S)-1-[[4-[(2S)-2-[[(2,4-dichlorophenyl)sulfonyl]amino]-3-hydroxy-1-oxopropyl]-1-piperazinyl]carbonyl]-3-methylbutyl]-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonamido)-3-hydroxypropanoyl)piperazin-1-yl)-4-methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxamide
CAS:Formula:C28H32Cl2N4O6S2Purity:98%Color and Shape:SolidMolecular weight:655.6129GSK1016790A
CAS:Formula:C28H32Cl2N4O6S2Purity:≥ 97%Color and Shape:White solidMolecular weight:655.61GSK1016790A
CAS:<p>GSK1016790A (GSK101) (GSK101) is a novel, potent activator of TRPV4 (transient receptor potential vanilloid 4) with EC50 of 34 nM in choroid plexus epithelial</p>Formula:C28H32Cl2N4O6S2Purity:97.37% - 99.38%Color and Shape:SolidMolecular weight:655.61GSK 1016790A
CAS:Controlled Product<p>Applications GSK 1016790A is a transient receptor potential vanilloid 4 (TRPV4) agonist.<br>References Egbuniwe, O., et. al.: J. Dent. Res., 93, 911 (2014); Yamawaki, H., et. al.: Am. J. Phys., 307, g33 (2014)<br></p>Formula:C28H32Cl2N4O6S2Color and Shape:NeatMolecular weight:655.61GSK1016790A
CAS:<p>GSK1016790A is a potent and selective small molecule inhibitor of TRPV4, a member of the transient receptor potential (TRP) channel family. It is currently being investigated for pharmacological effects in vitro and in vivo. GSK1016790A has been shown to inhibit the activity of TRPV4 channels in neuronal cells, leading to an increase in intracellular calcium levels and subsequent neuronal death. This agent also blocks the angiotensin system, which may have physiological implications including regulation of blood pressure. GSK1016790A binds to calcium binding sites on the cytosolic side of TRPV4 channels where it acts as a competitive antagonist. The compound is stable over a wide pH range and does not show any significant effect on cellular viability at concentrations up to 100 µM.</p>Formula:C28H32Cl2N4O6S2Purity:Min. 95%Molecular weight:655.61 g/mol






